4th Annual Induced Proximity-Based Drug Discovery Summit

Uniting Large Pharma, Innovative Biotech & Leading Academics to Radically Advance Heterobifunctional & Monovalent Drug Discovery Beyond Degradation

Whilst PROTACs continue to make headwind, much of the heterobifunctional and monovalent opportunity beyond the ubiquitin proteosome system remains untapped, drawing in new and distinguished biopharma in the race to develop new stabilization, modulation, post-translational modification, and inactivation/activation modalities. Taking on this emerging proximity phenomenon is no easy feat as knowledge gaps persist in validating novel mechanisms of action, accessing diverse chemical matter, and rationally designing selective and potent small molecules and biologics for novel target spaces.

Owing to this, the 4th Annual Induced Proximity-Based Drug Discovery Summit returns as the definitive and first established forum dedicated to gaining proof of concept for protein stabilization, modulation and post-translational modification.

As the community makes early strides, answer your burning questions with data-driven presentations, technical discussions, and interactive sessions as we unite 100+ induced proximity experts devoted to exploring the application of induced proximity in diverse fields in and beyond protein degradation.

What's New for 2024?

favicons

Extensive technical content covering the latest advancements in identifying, validating and developing DUBTACs, CyTACs, EpiTACs, PHICs, AUTOTACs, epigenetic modulators, chromatin remodellers, stabilizing and inactivating heterobifunctionals and molecular glues with improved selectivity and safety.

favicons

A new cohort of expert speakers and organizations presenting from the likes of Apertor Pharmaceuticals, EpiBiologics, Genentech, Magnet Biomedicine, Solu Therapeutics & Vicinitas Therapeutics.

favicons

Expert-led pre-conference workshops delving into aspirations of the induced proximity community, including fast-tracking target selection and validation and expanding the viable targets for stabilization by identifying novel protein partners for DUBTACs.

Induced Proximity Expert Speakers

Other events in the Small Molecules & TPD World Series